Phreesia, Inc. (NYSE:PHR) Receives Average Recommendation of "Buy" from Analysts

Phreesia, Inc. (NYSE:PHR - Get Free Report) has earned a consensus rating of "Buy" from the twelve ratings firms that are currently covering the company, Marketbeat reports. Twelve analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $31.33.

Several equities research analysts have issued reports on the company. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and raised their target price for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Needham & Company LLC reiterated a "buy" rating and set a $29.00 price target on shares of Phreesia in a research report on Thursday, March 13th. JMP Securities restated a "market outperform" rating and issued a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Robert W. Baird dropped their target price on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating for the company in a report on Wednesday, December 11th. Finally, Truist Financial upped their price target on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research note on Wednesday, December 11th.

Insider Activity

In other news, CFO Balaji Gandhi sold 28,759 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $30.00, for a total transaction of $862,770.00. Following the completion of the sale, the chief financial officer now owns 116,174 shares in the company, valued at approximately $3,485,220. The trade was a 19.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Amy Beth Vanduyn sold 1,311 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71. Following the completion of the transaction, the senior vice president now directly owns 115,633 shares in the company, valued at $3,076,994.13. This trade represents a 1.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 164,269 shares of company stock worth $4,661,469. 5.80% of the stock is currently owned by corporate insiders.

Remove Ads

Hedge Funds Weigh In On Phreesia

Several large investors have recently bought and sold shares of the stock. Invesco Ltd. boosted its position in shares of Phreesia by 0.9% in the 4th quarter. Invesco Ltd. now owns 40,249 shares of the company's stock valued at $1,013,000 after purchasing an additional 357 shares during the period. NewEdge Advisors LLC grew its position in shares of Phreesia by 12.1% during the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock worth $107,000 after acquiring an additional 459 shares during the last quarter. Johnson Financial Group Inc. raised its position in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. The Manufacturers Life Insurance Company increased its stake in Phreesia by 3.3% in the third quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company's stock valued at $637,000 after purchasing an additional 905 shares during the period. Finally, MetLife Investment Management LLC raised its holdings in shares of Phreesia by 3.8% in the third quarter. MetLife Investment Management LLC now owns 30,781 shares of the company's stock valued at $701,000 after buying an additional 1,120 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company's stock.

Phreesia Trading Down 4.2 %

NYSE:PHR traded down $1.06 on Tuesday, hitting $23.79. The stock had a trading volume of 349,397 shares, compared to its average volume of 429,683. The company has a fifty day moving average price of $27.24 and a two-hundred day moving average price of $24.22. Phreesia has a 1-year low of $17.07 and a 1-year high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a market cap of $1.40 billion, a price-to-earnings ratio of -16.18 and a beta of 0.82.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.